BoneSupport said last week it closed its initial public offering, raising a total of approximately $57.1 million (SEK 500 million), not including an over-allotment option.
The Swedish company, which is developing the Cerament G injectable antibiotic-eluting bone graft substitute, said it floated approximately 17.2 million new shares at $3.40 per share (SEK 29) in the round, raising approximately $57.1 million before issue costs and $54 million (SEK 461 million) after issue costs.
Read the whole story at our sister site, Drug Delivery Business
The post Bonesupport closes $57m IPO appeared first on MassDevice.
from MassDevice http://ift.tt/2t4z4Dj
Cap comentari:
Publica un comentari a l'entrada